|
ELK3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99089997213287E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.36539693282612E-12 |
| Normal-vs-Stage2 |
6.464500E-02 |
| Normal-vs-Stage3 |
9.884800E-03 |
| Normal-vs-Stage4 |
1.550380E-01 |
| Stage1-vs-Stage2 |
5.075800E-03 |
| Stage1-vs-Stage3 |
5.84439999999908E-05 |
| Stage1-vs-Stage4 |
2.204600E-03 |
| Stage2-vs-Stage3 |
9.213400E-01 |
| Stage2-vs-Stage4 |
7.784400E-01 |
| Stage3-vs-Stage4 |
7.926400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59140003794545E-09 |
| Normal-vs-AfricanAmerican |
5.687600E-02 |
| Normal-vs-Asian |
9.633800E-02 |
| Caucasian-vs-AfricanAmerican |
7.739400E-01 |
| Caucasian-vs-Asian |
1.066640E-01 |
| AfricanAmerican-vs-Asian |
2.222000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17119999978976E-07 |
| Normal-vs-Female |
4.0734999995351E-07 |
| Male-vs-Female |
6.729600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.778500E-02 |
| Normal-vs-Age(41-60Yrs) |
9.76460001744783E-09 |
| Normal-vs-Age(61-80Yrs) |
3.52930000000473E-05 |
| Normal-vs-Age(81-100Yrs) |
6.409800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.298800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.228200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.528400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.128400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.255910E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.980390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.017400E-03 |
| Normal-vs-Grade 2 |
1.24480425967022E-11 |
| Normal-vs-Grade 3 |
6.344000E-03 |
| Normal-vs-Grade 4 |
1.291410E-01 |
| Grade 1-vs-Grade 2 |
5.678100E-02 |
| Grade 1-vs-Grade 3 |
2.333800E-02 |
| Grade 1-vs-Grade 4 |
4.103400E-03 |
| Grade 2-vs-Grade 3 |
1.34070000001874E-06 |
| Grade 2-vs-Grade 4 |
5.518700E-03 |
| Grade 3-vs-Grade 4 |
9.242400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.18559606576696E-11 |
| Normal-vs-ccB subtype |
2.370800E-04 |
| ccA subtype-vs-ccB subtype |
2.594000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8018899999972E-05 |
| Normal-vs-N1 |
2.911000E-01 |
| N0-vs-N1 |
6.917600E-01 |
|
|
